Benjamin J. Hindson - Net Worth and Insider Trading

Benjamin J. Hindson Net Worth

The estimated net worth of Benjamin J. Hindson is at least $10 Million dollars as of 2023-02-06. Benjamin J. Hindson is the See Remarks of 10x Genomics Inc and owns about 217,713 shares of 10x Genomics Inc (TXG) stock worth over $10 Million. Details can be seen in Benjamin J. Hindson's Latest Holdings Summary section.

Transaction Summary of Benjamin J. Hindson

To

Benjamin J. Hindson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benjamin J. Hindson owns 1 companies in total, including 10x Genomics Inc (TXG) .

Click here to see the complete history of Benjamin J. Hindson’s form 4 insider trades.

Insider Ownership Summary of Benjamin J. Hindson

Ticker Comapny Transaction Date Type of Owner
TXG 10x Genomics Inc 2019-09-11 director & See Remarks

Benjamin J. Hindson Latest Holdings Summary

Benjamin J. Hindson currently owns a total of 1 stock. Benjamin J. Hindson owns 217,713 shares of 10x Genomics Inc (TXG) as of November 22, 2022, with a value of $10 Million.

Latest Holdings of Benjamin J. Hindson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TXG 10x Genomics Inc 2022-11-22 217,713 47.84 10,415,390

Holding Weightings of Benjamin J. Hindson

Benjamin J. Hindson Form 4 Trading Tracker

According to the SEC Form 4 filings, Benjamin J. Hindson has made a total of 26 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in 10x Genomics Inc is the sale of 2,361 shares on November 22, 2022, which brought Benjamin J. Hindson around $80,439.

Insider Trading History of Benjamin J. Hindson

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
TXG
10x Genomics Inc
2022-11-22
Sell
2,361.00
-1.07%
$34.07
$80,439.30
217,713.00
$47.84
40.42%
2022-11-23
TXG
10x Genomics Inc
2022-08-23
Sell
1,292.00
-0.69%
$35.19
$45,465.50
186,246.00
$47.84
35.95%
2022-08-25
TXG
10x Genomics Inc
2022-05-23
Sell
1,264.00
-0.67%
$48.76
$61,632.60
187,538.00
$47.84
-1.89%
2022-05-25
TXG
10x Genomics Inc
2021-12-01
Sell
41,666.00
-47.12%
$148.08
$6,169,900.00
46,766.00
$47.84
-67.69%
-
TXG
10x Genomics Inc
2021-11-01
Sell
41,666.00
-46.93%
$163.58
$6,815,720.00
47,117.00
$47.84
-70.75%
-
TXG
10x Genomics Inc
2021-10-01
Sell
41,666.00
-46.93%
$143.56
$5,981,570.00
47,117.00
$47.84
-66.68%
-
TXG
10x Genomics Inc
2021-09-01
Sell
41,666.00
-46.93%
$177.50
$7,395,720.00
47,117.00
$47.84
-73.05%
-
TXG
10x Genomics Inc
2021-08-02
Sell
41,666.00
-46.75%
$180.35
$7,514,460.00
47,454.00
$47.84
-73.47%
-
TXG
10x Genomics Inc
2021-05-03
Sell
41,666.00
-53.21%
$191.84
$7,993,210.00
36,636.00
$47.84
-75.06%
-
TXG
10x Genomics Inc
2021-03-12
Sell
41,666.00
-53.21%
$156.98
$6,540,730.00
36,636.00
$47.84
-69.52%
-
TXG
10x Genomics Inc
2021-02-01
Sell
33,750.00
-47.95%
$175.98
$5,939,320.00
36,636.00
$47.84
-72.82%
-
TXG
10x Genomics Inc
2021-01-04
Sell
33,750.00
-32.41%
$139.93
$4,722,640.00
70,386.00
$47.84
-65.81%
-
TXG
10x Genomics Inc
2020-12-01
Sell
33,750.00
-33.33%
$151.32
$5,107,050.00
67,500.00
$47.84
-68.38%
-
TXG
10x Genomics Inc
2020-11-03
Sell
33,750.00
-33.33%
$136.68
$4,612,950.00
67,500.00
$47.84
-65.00%
-
TXG
10x Genomics Inc
2020-10-01
Sell
33,750.00
-33.33%
$125.54
$4,236,980.00
67,500.00
$47.84
-61.89%
-
TXG
10x Genomics Inc
2020-09-02
Sell
33,750.00
-33.33%
$113.64
$3,835,350.00
67,500.00
$47.84
-57.90%
-
TXG
10x Genomics Inc
2020-08-03
Sell
33,750.00
-33.33%
$99.34
$3,352,720.00
67,500.00
$47.84
-51.84%
-
TXG
10x Genomics Inc
2020-07-01
Sell
33,750.00
-33.33%
$87.60
$2,956,500.00
67,500.00
$47.84
-45.39%
-
TXG
10x Genomics Inc
2020-06-01
Sell
33,750.00
-33.33%
$79.85
$2,694,940.00
67,500.00
$47.84
-40.09%
-
TXG
10x Genomics Inc
2020-05-01
Sell
33,750.00
-33.33%
$77.38
$2,611,580.00
67,500.00
$47.84
-38.18%
-
Total 22
  • 1
  • 2
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Benjamin J. Hindson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Benjamin J. Hindson Ownership Network

Ownership Network List of Benjamin J. Hindson

No Data

Ownership Network Relation of Benjamin J. Hindson

Benjamin J. Hindson Owned Company Details

Benjamin J. Hindson Mailing Address

Above is the net worth, insider trading, and ownership report for Benjamin J. Hindson. You might contact Benjamin J. Hindson via mailing address: 10x Genomics, Inc., 6230 Stoneridge Mall Road, Pleasanton Ca 94588.

Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today Global Market Valuation Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF ADV Part 2A ADV Part 2B ADV Part 3 Advertise Site Map Term of Use Privacy Policy Referral Program Affiliate Program
Follow Us
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.
© 2004-2023 GuruFocus.com, LLC. All Rights Reserved.